{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:32:24Z","timestamp":1792211544448,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jtct.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T08:03:41Z","timestamp":1613462621000},"page":"433.e1-433.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host Disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Zhonghui K.","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar A.","family":"Domenech-Estarellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Armand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Koreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahasweta","family":"Gooptu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin P.","family":"Alyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Soiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent T.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.02.008_bib0001","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2021.02.008_bib0002","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","article-title":"Current issues in chronic graft-versus-host disease","volume":"124","author":"Soci\u00e9","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.02.008_bib0003","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/ACI.0b013e328357b4b9","article-title":"Ocular graft-versus-host disease","volume":"12","author":"Hessen","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jtct.2021.02.008_bib0004","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41409-018-0340-0","article-title":"Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT","volume":"54","author":"Inamoto","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.02.008_bib0005","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1167\/iovs.02-0699","article-title":"Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease","volume":"44","author":"Ogawa","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.02.008_bib0006","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jtos.2017.08.002","article-title":"Conjunctival subepithelial fibrosis and meibomian gland atrophy in ocular graft-versus-host disease","volume":"15","author":"Kusne","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.02.008_bib0007","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.bmt.1705725","article-title":"Treatment of refractory chronic GVHD with rituximab: a GITMO study","volume":"40","author":"Zaja","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.02.008_bib0008","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2009.04.003","article-title":"Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis","volume":"15","author":"Kharfan-Dabaja","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.02.008_bib0009","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00417-019-04301-6","article-title":"Ocular surface system alterations in ocular graft-versus-host disease: all the pieces of the complex puzzle","volume":"257","author":"Giannaccare","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtct.2021.02.008_bib0010","first-page":"351","article-title":"Ocular graft-versus-host disease following allogeneic stem cell transplantation: a review of current knowledge and recommendations","volume":"8","author":"Nassiri","year":"2013","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.jtct.2021.02.008_bib0011","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.bbmt.2015.05.020","article-title":"Impact of ocular chronic graft-versus-host disease on quality of life","volume":"21","author":"Sun","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.02.008_bib0012","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.ophtha.2015.04.011","article-title":"Vision-related quality of life in patients with ocular graft-versus-host disease","volume":"122","author":"Saboo","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtct.2021.02.008_bib0013","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ICO.0b013e318226bf97","article-title":"Diagnosis and treatment of ocular chronic graft-versus-host disease: report From the German-Austrian-Swiss Consensus Conference on Clinical Practics in Chronic GVHD","volume":"31","author":"Dietrich-Ntoukas","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtct.2021.02.008_bib0014","first-page":"21","article-title":"Chronic ocular graft versus host disease: an update and review","volume":"3","author":"Groth","year":"2020","journal-title":"J Dry Eye Ocul Surf Dis"},{"key":"10.1016\/j.jtct.2021.02.008_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.ico.0000240101.66652.36","article-title":"Perforated corneal ulcer with subsequent endophthalmitis in a patient with graft-versus-host disease","volume":"26","author":"Adrean","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jtct.2021.02.008_bib0016","first-page":"598","article-title":"Four cases of corneal perforation in patients with chronic graft-versus-host disease","volume":"17","author":"Inagaki","year":"2011","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtct.2021.02.008_bib0017","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.286.17.2114","article-title":"Hormone replacement therapy and dry eye syndrome","volume":"286","author":"Schaumberg","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.02.008_bib0018","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1167\/iovs.18-26049","article-title":"Progesterone application to the rat forehead produces corneal antinociception","volume":"60","author":"Meng","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.02.008_bib0019","first-page":"111","article-title":"A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD","volume":"42","author":"Ogawa","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.02.008_bib0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.02.008_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.02.008_bib0022","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41409-018-0090-z","article-title":"Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation","volume":"53","author":"Pathak","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.02.008_bib0023","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/ICO.0000000000000340","article-title":"Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation","volume":"34","author":"Shikari","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtct.2021.02.008_bib0024","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","article-title":"The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.02.008_bib0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","article-title":"Development and validation of a short global dry eye symptom index","volume":"5","author":"Schaumberg","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.02.008_bib0026","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.jtct.2021.02.008_bib0027","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3324\/haematol.2015.124131","article-title":"Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice","volume":"100","author":"Curtis","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2021.02.008_bib0028","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jtos.2018.05.002","article-title":"Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD","volume":"16","author":"Amparo","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.02.008_bib0029","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jtos.2016.04.003","article-title":"Superior limbic keratoconjunctivitis-like inflammation in patients with chronic graft-versus-host disease","volume":"14","author":"Sivaraman","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtct.2021.02.008_bib0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.icu.0000233952.09595.d8","article-title":"Update on ocular graft versus host disease","volume":"17","author":"Kim","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jtct.2021.02.008_bib0031","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00003226-200404000-00010","article-title":"The repeatability of clinical measurements of dry eye","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.jtct.2021.02.008_bib0032","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbmt.2011.04.002","article-title":"A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change","volume":"17","author":"Mitchell","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.02.008_bib0033","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ophtha.2011.08.040","article-title":"Validation of measurement scales in ocular graft-versus-host disease","volume":"119","author":"Inamoto","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtct.2021.02.008_bib0034","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/bbmt.2002.v8.pm12234170","article-title":"Development and validation of a scale to measure symptoms of chronic graft-versus-host disease","volume":"8","author":"Lee","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.02.008_bib0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbmt.2019.11.020","article-title":"Reliability and validity of the modified 7-day Lee chronic graft-versus-host disease Symptom Scale","volume":"26","author":"Teh","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.02.008_bib0036","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.pain.2008.06.016","article-title":"Fast non-genomic effects of progesterone-derived neurosteroids on nociceptive thresholds and pain symptoms","volume":"139","author":"Charlet","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jtct.2021.02.008_bib0037","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1283","article-title":"Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model","volume":"3","author":"Norman","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jtct.2021.02.008_bib0038","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.exer.2013.08.011","article-title":"The role of corneal afferent neurons in regulating tears under normal and dry eye conditions","volume":"117","author":"Meng","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtct.2021.02.008_bib0039","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1167\/iovs.12-10025","article-title":"Menthol activation of corneal cool cells induces TRPM8-mediated lacrimation but not nociceptive responses in rodents","volume":"53","author":"Robbins","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtct.2021.02.008_bib0040","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1167\/iovs.09-4744","article-title":"Cold-sensitive corneal afferents respond to a variety of ocular stimuli central to tear production: implications for dry eye disease","volume":"51","author":"Hirata","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721006746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721006746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:00:20Z","timestamp":1763002820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721006746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2666636721006746"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.02.008","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}